Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series

Authors: Lee, Richard T., Yang, Peiying, Alahmadi, Asrar, McQuade, Jennifer, Yuan, Eric, Difeo, Analisa, Narla, Goutham, Kaseb, Ahmed

Source: Case reports in oncology. 14(1):224-231

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121329721.0x000001&indx=1&recIds=ETOCvdc_100121329721.0x000001

STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?

Authors: Huvila, Jutta, Cochrane, Dawn R, Ta, Monica, Chow, Christine, Greening, Kendall, Leung, Samuel, Karnezis, Anthony N, DiFeo, Analisa, Huntsman, David G

Source: Journal of pathology.Clinical research. 7(6):548-555

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100131840015.0x000001&indx=1&recIds=ETOCvdc_100131840015.0x000001

miR-181a: regulatory roles, cancer-associated signaling pathway disruptions, and therapeutic potential.

Authors: McIntyre, Grace, Jackson, Zoe, Colina, Jose, Sekhar, Sreeja, DiFeo, Analisa

Source: Expert Opinion on Therapeutic Targets; Dec2024, Vol. 28 Issue 12, p1061-1091, 31p

Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas.

Authors: Knarr, Matthew J., Moon, Jamie, Rawat, Priyanka, DiFeo, Analisa, Hoon, David S. B., Drapkin, Ronny

Source: Science Signaling; 11/19/2024, Vol. 17 Issue 863, p1-17, 17p

Subject Terms: EPITHELIAL cell culture, FORSKOLIN, CYCLIC adenylic acid, FALLOPIAN tubes, CANCER chemotherapy

Low PPP2R2A expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer.

Authors: Zhaojun Qiu, Deepika Sigh, Yujie Liu, Prasad, Chandra B., Bean, Nichalos, Chunhong Yan, Zaibo Li, Xiaoli Zhang, Narla, Goutham, DiFeo, Analisa, Qi-En Wang, Junran Zhang

Source: Theranostics; 2024, Vol. 14 Issue 19, p7450-7469, 20p

A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs

Authors: Belur Nagaraj, Anil, Joseph, Peronne, Ponting, Erin, Fedorov, Yuriy, Singh, Salendra, Cole, Alex, Lee, Woncheol, Yoon, Euisik, Baccarini, Alessia, Scacheri, Peter, Buckanovich, Ronald, Adams, Drew J., Drapkin, Ronny, Brown, Brian D., DiFeo, Analisa

Source: In Stem Cell Reports 8 January 2019 12(1):122-134

Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

Authors: Belur Nagaraj, Anil, Joseph, Peronne, Kovalenko, Olga, Wang, QuanQiu, Xu, Rong, DiFeo, Analisa

Source: In Gynecologic Oncology December 2018 151(3):525-532

MiR-181a modulates circadian rhythm in immortalized bone marrow and adipose derived stromal cells and promotes differentiation through the regulation of PER3

Authors: Knarr, Matthew, Nagaraj, Anil, Kwiatkowski, Lily, DiFeo, Analisa

Source: Scientific reports. 9(1):1-13

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111629331.0x000001&indx=1&recIds=ETOCvdc_100111629331.0x000001

Effects of Metformin on Cellular Proliferation and Steroid Hormone Receptors in Patient-Derived, Low-Grade Endometrial Cancer Cell Lines

Authors: Collins, Gretchen, Mesiano, Sam, DiFeo, Analisa

Source: Reproductive sciences. 26(5):609-618

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN620102027&indx=1&recIds=ETOCRN620102027

Repurposed Drugs Trials for Ovarian Cancer

Authors: DiFeo, Analisa

Source: Cancer journal. 25(2):149-152

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100078939933.0x000001&indx=1&recIds=ETOCvdc_100078939933.0x000001

Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection.

Authors: Centeno, Daniel, Farsinejad, Sadaf, Kochetkova, Elena, Volpari, Tatiana, Gladych-Macioszek, Aleksandra, Klupczynska-Gabryszak, Agnieszka, Polotaye, Teagan, Greenberg, Michael, Kung, Douglas, Hyde, Emily, Alshehri, Sarah, Pavlovic, Tonja, Sullivan, William, Plewa, Szymon, Vakifahmetoglu-Norberg, Helin, Monsma Jr., Frederick J., Muller, Patricia A. J., Matysiak, Jan, Zaborowski, Mikołaj Piotr, DiFeo, Analisa

Source: Nutrients; Jun2024, Vol. 16 Issue 12, p1816, 25p

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease

Authors: Sivendran, Shanthi ^{1, 2, 18}, Chang, Rui ^{3, 18, *}, Pham, Lisa ³, Phelps, Robert G. ^{4, 5}, Harcharik, Sara T. ⁴, Hall, Lawrence D. ⁶, Bernardo, Sebastian G. ⁴, Moskalenko, Marina M. ¹, Sivendran, Meera ⁶, Fu, Yichun ¹, de Moll, Ellen H. ¹, Pan, Michael ¹, Moon, Jee Young ³, Arora, Sonali ³, Cohain, Ariella ³, DiFeo, Analisa ⁷, Ferringer, Tammie C. ⁸, Tismenetsky, Mikhail ^{5, 9}, Tsui, Cindy L. ⁴, Friedlander, Philip A. ¹, Parides, Michael K. ¹⁰, Banchereau, Jacques ¹¹, Chaussabel, Damien ¹², Lebwohl, Mark G. ⁴, Wolchok, Jedd D. ¹³, Bhardwaj, Nina ^{1, 14, 15}, Burakoff, Steven J. ¹, Oh, William K. ¹, Palucka, Karolina ^{1, 16}, Merad, Miriam ^{1, 17}, Schadt, Eric E. ³, Saenger, Yvonne M. ^{1, 4, *}

Source: In Journal of Investigative Dermatology August 2014 134(8):2202-2211

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer.

Authors: Bustos, Matias A., Yokoe, Takamichi, Shoji, Yoshiaki, Kobayashi, Yuta, Mizuno, Shodai, Murakami, Tomohiro, Zhang, Xiaoqing, Sekhar, Sreeja C., Kim, SooMin, Ryu, Suyeon, Knarr, Matthew, Vasilev, Steven A., DiFeo, Analisa, Drapkin, Ronny, Hoon, Dave S. B.

Source: Cell & Bioscience; 11/6/2023, Vol. 13 Issue 1, p1-18, 18p

Subject Terms: TRIPLE-negative breast cancer, OVARIAN cancer, POLY ADP ribose, POLY(ADP-ribose) polymerase, INTERFERON gamma, GENE expression, TYPE I interferons, VENOM

MiR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling

Authors: Knarr, Matthew, Avelar, Rita A., Sekhar, Sreeja C., Kwiatkowski, Lily J., Dziubinski, Michele L., McAnulty, Jessica, Skala, Stephanie, Avril, Stefanie, Drapkin, Ronny, DiFeo, Analisa

Source: Nature communications. 11(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100174577886.0x000001&indx=1&recIds=ETOCvdc_100174577886.0x000001

MiRNAs as prognostic and therapeutic tools in epithelial ovarian cancer

Authors: Nagaraj, Anil Belur, Joseph, Peronne, DiFeo, Analisa

Source: Biomarkers in medicine. 9(3):241-257

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100123896932.0x000001&indx=1&recIds=ETOCvdc_100123896932.0x000001

Ligand-dependent Corepressor (LCoR) Recruitment by Krüppel-like Factor 6 (KLF6) Regulates Expression of the Cyclin-dependent Kinase Inhibitor CDKN1A Gene

Authors: Calderon, Mario R., Verway, Mark, An, Beum-Soo, DiFeo, Analisa, Bismar, Tarek A., Ann, David K., Martignetti, John A., Shalom-Barak, Tali ^**, White, John H.

Source: In Journal of Biological Chemistry 16 March 2012 287(12):8662-8674

Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway

Authors: A. Avelar, Rita, Gupta, Riya, Carvette, Grace, da Veiga Leprevost, Felipe, Jasti, Medhasri, Colina, Jose, Teitel, Jessica, Nesvizhskii, Alexey I., O’Connor, Caitlin M., Hatzoglou, Maria, Shenolikar, Shirish, Arvan, Peter, Narla, Goutham, DiFeo, Analisa

Source: Cell Death and Differentiation; 20240101, Issue: Preprints p1-15, 15p

Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity

Authors: Sanborn, Keri B., Mace, Emily M., Rak, Gregory D., Difeo, Analisa, Martignetti, John A., Pecci, Alessandro, Bussel, James B., Favier, Rémi, Orange, Jordan S.

Source: In Blood 24 November 2011 118(22):5862-5871

The role of KLF6 and its splice variants in cancer therapy

Authors: DiFeo, Analisa, Martignetti, John A., Narla, Goutham

Source: In Drug Resistance Updates 2009 12(1):1-7

Functional role of the KLF6 tumour suppressor gene in gastric cancer

Authors: Sangodkar, Jaya, Shi, Jiayan, DiFeo, Analisa, Schwartz, Rachel, Bromberg, Romina, Choudhri, Aisha, McClinch, Kim, Hatami, Raheleh, Scheer, Elias, Kremer-Tal, Sigal, Martignetti, John A, Hui, Alex, Leung, W.K., Friedman, Scott L., Narla, Goutham

Source: In European Journal of Cancer 2009 45(4):666-676